About Hema Biologics
Hema Biologics is a Pharmaceuticals company, headquartered in Louisville, with 11 - 50 employees and annual revenue of $5M - $20M.
HEMA Biologics is a privately held biopharmaceutical company exclusively focused on meeting the needs of patients living with the rarest bleeding disorders. We aspire to support patients living with these disorders, partner with the broader community that cares for them, and bring meaningful treatme...
Seamless Pro Tip
Use this information to figure out if this company is an ideal customer for you.
Hema Biologics Company Highlights
Phone Number
(502) 815-xxxx
Corporate Office Address
4441 Springdale Road
Louisville, 40241
Website
Hema Biologics Org
Hema Biologics has 1 VP, 8 Director, 16 Manager, 1 Senior, and 2 Other employees.
Hema Biologics's Tech Stack
Frequently Asked Questions About
Hema Biologics
Log in or sign up to get full contact details and additional support.
How many senior employees does Hema Biologics have?
Hema Biologics has 26 senior employees that are typically used for decision making.
What technologies does Hema Biologics use?
Hema Biologics uses technologies including Choices, Cloudflare, and Cookie Notice.
How do I contact Hema Biologics?
To contact Hema Biologics, visit hemabio.com.
What companies are similar to Hema Biologics?
Companies similar to Hema Biologics include MSD Animal Health, Madrigal Pharmaceuticals, and Pharmaceutical Industry.
Where is Hema Biologics headquartered?
Hema Biologics is headquartered at 4441 Springdale Road, Louisville.
What is the main phone number for Hema Biologics?
The main phone number for Hema Biologics is (502) 815-xxxx.
What is the official website for Hema Biologics?
The official website for Hema Biologics is hemabio.com.
What is the annual revenue of Hema Biologics?
The annual revenue of Hema Biologics is $5M - $20M.
How many employees does Hema Biologics have?
Hema Biologics has 11 - 50 employees.
What industry is Hema Biologics in?
Hema Biologics is in the Pharmaceuticals industry.
Last updated: August 19, 2024